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Abstract
Background: Major depressive disorder in people living with HIV/AIDS (PLWHA) is common and may be associated with a
number of factors, including AIDS-related stigma, decreased CD4 levels, increased opportunistic infections and
sociodemographic variables. The extent to which AIDS-related stigma is associated with major depressive disorder among
PLWHA has not been well studied in sub-Saharan Africa. The objective of this study was to examine the associations
between major depressive disorder, AIDS-related stigma, immune status, and sociodemographic variables with the aim of
making recommendations that can guide clinicians.
Methods: We assessed 368 PLWHA for major depressive disorder, as well as for potentially associated factors, including
AIDS-related stigma, CD4 levels, presence of opportunistic infections, and sociodemographic variables.
Results: The prevalence of major depressive disorder was 17.4%, while 7.9% of the participants had AIDS related stigma. At
multivariable analysis, major depressive disorder was significantly associated with AIDS-related stigma [OR= 1.65, CI (1.20–
2.26)], a CD4 count of $200 [OR 0.52 CI (0.27–0.99)], and being of younger age [0.95, CI (0.92–0.98).
Conclusions: Due to the high burden of major depressive disorder, and its association with AIDS related stigma, routine
screening of PLWHA for both conditions is recommended. However, more research is required to understand this
association.
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Introduction
HIV/AIDS is one of the biggest health crises the world faces
today, with close to two-thirds of all people living with HIV/AIDS
(PLWHA) residing in sub-Saharan Africa [1]. The prevalence of
HIV/AIDS in Uganda in 2012 stood at 7.2%, with women
disproportionately represented [2]. The recent ministry of health
demographic survey put the prevalence of HIV/AIDS at 8.3% in
women and 6.1% in men [2]. Treatment coverage for PLWHA is
poor in Uganda, with only half of PLWHA accessing antiretroviral
therapy (ART) [3].
Among PLWHA, depressive disorder is the commonest
neuropsychiatric disorder, occurring at rates two to three times
higher than in HIV-negative patients [4–6]. The prevalence of
depressive disorder among PLWHA in Uganda has been reported
as 20–40% [7–10]. Depressive disorder in PLWHA has been
associated with several critical adverse health- related outcomes.
Previous work has documented poor adherence to medications,
including ART in depressed PLWHA [11–13]. Other researchers
have also documented that PLWHA suffering from depression
progress faster from HIV to AIDS compared to non-depressed
PLWHA [14–17]. Compared to depressed HIV negative persons,
PLWHA who suffer from depression have also been shown to have
a poor quality of life [18].
The development of depressive disorder among PLWHA is
likely the result of a combination of biological and sociodemo-
graphic variables [14,19–22]. Some of these biological variables
may be relatively unique to PLWHA, such as AIDS-related stigma
[20,21], compromised immune status (low CD4 counts) and
increased opportunistic infections [19,23,24]. However, socio-
demographic variables including gender, low education and lack
of employment have been associated with depression in both HIV
negative and positive populations [22,25,26]
AIDS- related stigma is prominent among PLWHA and has
been shown to negatively impact on the quality of life, leading to
poor functioning of affected individuals [27,28]. Research has also
shown that PLWHA who have stigma are less likely to access HIV
care services [27,29,30],and could have poor psychological
wellbeing [21,31]. Some work done in South Africa has
documented increased burden of AIDS stigma and its association
with mental disorders [20,32]. Despite its prominence, AIDS
related stigma among PLWHA is often unidentified [28,30,32,33].
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The dual existence of AIDS related stigma and major depressive
disorder among PLWHA could lead to a number of adverse health
outcomes. However, little work has been done to particularly
assess the association between AIDS related stigma and major
depressive disorder in sub-Saharan Africa [20,32,33]. Examining
the relationship between AIDS related stigma and major
depressive could prove useful in raising clinician’s awareness
about the need to holistically assess PLWHA who present at PHC.
Similarly, literature about the other factors that may be
associated with major depressive disorder, including immunolog-
ical and sociodemographic variables in PLWHA is less consistent.
Thus while some work has reported that a low CD4 count is
associated with having depression in PLWHA [15,17], other
researchers have found otherwise [22,34]. Research findings about
the association between major depressive disorder and female
gender [22,35], being of younger age [35–37] and unemployment
[37] have equally shown inconsistencies. Examining the associa-
tion between depression and these factors is important since some
of them have been shown to influence health outcomes in
PLWHA [15,19,22].
In this study, we investigated the extent to which major
depressive disorder was associated with AIDS-related stigma, and
a number of other variables in PLWHA with the aim of making
recommendations that can guide clinicians.
Methods
Study design and setting
This was a cross sectional study which took place at the
Nsambya Hospital Home care department, an HIV-PHC facility
3 km from Kampala city, between the months of April and June
2011.
Study population
The study population consisted of PLWHA who were medically
stable and had been in care for atleast 6 months. Patients were
excluded if they presented with a mental illness requiring
admission.
Study procedure
About 150–200 patients attend the clinic daily; each of them is
given a number based on time of arrival (1–200 for example).
Using EPIDATA, we randomly generated 15–20 numbers daily,
each number belonging to a potential clinic attendee, who would
be approached and informed consent obtained. Triage nurses then
administered the patient health questionnaire-9(PHQ-9) [38] to
screen for depression.
Research assistants, who were medical Doctors and holders of
an MBChB degree, and were trained by the principal investigator,
administered the study instruments. The presence of a current
major depressive disorder, according to the Mini International
Neuropsychiatric Inventory (MINI) [39] depression module was
confirmed by the research assistants. The presence of bipolar
depression was ruled out by asking whether patients had ever had
an episode of mania or hypomania. Such patients (5 in number)
were not included in the final analysis. The research assistants also
administered the sociodemographic questionnaire and the AIDS-
related stigma scale to all consented patients. The PHQ-9 was
administered as part of a validation study, the findings of which
will be reported elsewhere. Research assistants abstracted the most
recent CD4 count level from patient’s charts. All the question-
naires were translated from English into the local language
(Luganda), and administered in either language, depending on
which of the two was understood by the patient.
Ethical approval
The study was approved by the Makerere University School of
Medicine Ethics committee and the University of Cape Town
Health Sciences Human Research Ethics Committees. Study
participants received a transport refund of 10,000 Ugandan
shillings (approximately4$).
Study instruments
The MINI was designed as a brief structured interview for
diagnosing the major Axis I psychiatric disorders in DSM-IV and
can be administered in 18.7611.6 minutes (median 15 minutes).
The MINI has been used in a number of studies as a diagnostic
instrument among PLWHA in Uganda [7,35,36,40].
AIDS related stigma scale [41] is a 9 item that developed for use
in sub-Saharan Africa. It was validated among 2300 patients, and
showed good psychometric properties. The internal consistency of
the scale was 0.75, and was time stable over three months r = 0.67.
The 9- item AIDS related stigma scale taps into a broad range of
stigmatizing beliefs including negative beliefs towards self and
others (internalized and enacted variables of stigma) [41].
Sociodemographic information, presence of opportunistic
infections and CD4 counts was collected from all participants
using a standardized questionnaire.
The PHQ-9 was adapted from the primary care evaluation of
mental disorders (PRIME MD) screening questionnaire for
depressive symptoms, and has 9 questions with a score ranging
from 0 to 3 for each question (maximum score of 27). A threshold
score of 10 or higher is considered to indicate mild major
depressive disorder, 15 or higher indicates moderate major
depressive disorder, and 20 or higher severe major depressive
disorder. The internal consistency of the PHQ-9 was 0.65 [42]
The PHQ-9 has not been validated in Uganda; however, it was
validated among PLWHA in Kenya providing good psychometric
properties with a coefficient alpha of 0.78. [43].
Study measures
A diagnosis of a major depressive disorder was arrived at if
participants had atleast 5 of the 9 DSM-IV-TR symptoms for
major depression, and were judged to have social and occupa-
tional impairments as a result of the symptoms. Persons diagnosed
as depressed were referred to the attending clinic medical officer
for treatment. AIDS related stigma was diagnosed if patients
positively endorsed atleast 5 out of the nine questions. Persons
diagnosed with AIDS-related stigma were referred to the hospital
counsellor.
Data Analysis
Data was analysed using STATA 11.2 [44]. We initially
compared individuals with and without major depressive disorder
using bivariate analysis; variables that were statistically significant
at bivariate analysis were then entered into a multivariable model
following a stepwise hierarchical format. Logistic regression was
used to test for significant associations, controlling for age and
gender. Major depressive disorder was the dependent variable,
with AIDS related stigma, immune status and sociodemographic
variables as independent variables. We also assessed whether the
sociodemographic and clinical variables were confounding the
association between AIDS related stigma and Major depression.
Results
The mean age of the respondents was 38.8 years (SD 9.81;
range 18–71). Of the 368 participants, 72% were female. About
two thirds (65.5%) had some form of employment, and only 196
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(53.8%) had attained at least secondary education. Mean CD4+
was 329.70, (SD 183.95; range 1–999). Median CD4+ was 336,
inter-quartile range 25–75% (250–356). The prevalence of major
depressive disorder was 17.4%. Twenty nine out of the 368
participants (7.9%) had AIDS related stigma. (See table 1).
At bivariate analysis, participants with major depressive
disorder were more likely to have AIDS-related stigma [OR
1.61, CI (1.19–2.17)], an opportunistic infection [OR 1.89, CI
(1.05–3.38)], and a lower CD4 $200) [OR 0.52 CI (0.27–0.99)].
Being of younger age [OR 0.42 CI (0.19–0.92)], lacking
employment [OR 0.53, CI (0.30–0.91)] and having a lower
education [OR 0.48, CI (0.27–0.84)] were also associated with
depression at bivariate analysis. (See table 2).
We included all statistically significant variables in the logistic
regression model, and used a stepwise hierarchical model analysis
method. In the final model, major depressive disorder was
associated with AIDS-related stigma [(OR=1.65, CI 1.20–
2.26)], CD4+ counts of $200 [OR 0.43, (CI 0.20–0.91)] and a
younger age [OR0.95, CI 0.92–0.98)]. (See table 3).
Discussion
Major depressive disorder was prevalent in our study popula-
tion, occurring in 17.4% of the participants. Previous studies
conducted among PLWHA in Uganda have reported higher
depression prevalence [9,45]; findings which could be explained
by the fact that in those studies, the diagnosis of depression was
Table 1. Sociodemographic and clinical characteristics of the
respondents.
Variable Frequency(%)
Major depression
Yes 64(17.39%)
No 304(82.61%)
Gender
Male 107(29%)
Female 261(71%)
Age
18–29 65(17.7%)
30–39 144(39.1%)
40–49 108(29.3%)
50+ 51(13.8%)
Age(Mean(sd)) 38.84(10.08)
AIDS stigma
Yes 29(7.88%)
No 339(92.1%)
Marital status
Not married 229(62.2%)
Married 139(37.8%)
Employment
Employed 241(65.5%)
Not employed 127(34.5%)
Education status
Primary education 170(46.2%)
Secondary Education 198(53.8%)
CD4 counts
,200 61(16.6%)
.201 307(83.4%)
CD4(Mean(sd)) 328.22(182.36)
Median 336 IQR 25–75%(250–356)
Opportunistic Infection
Yes 154(41.8%)
No 214(58.2%)
WHO stage
I 92(25%)
II 135(36.7%)
III 95(25.8%)
IV 41(11.1%)
doi:10.1371/journal.pone.0048671.t001
Table 2. Bivariate analysis of the sociodemographic and
clinical characteristics of the respondents.
Variable Depressed Not depressed P-value
(frequency, %) (frequency, %)
Gender
Male 18 (16.82) 89(83.18)
Female 46(17.62) 215(82.38) 0.854
Age
18–29 17(26.15) 48 (73.85)
30–39 27(18.75) 117(81.25) 0.068
40–49 14(12.96) 94(87.04) 0.014*
50+ 6(11.76) 45(88.24) 0.034*
AIDS stigma
Yes 10 (34.48) 19(65.52) 0.002*
No 54(15.93) 285(84.07)
Marital status
Not married 37 (16.16) 192(83.84)
Married 27(19.42) 112(80.58) 0.423
Employment
Employed 34(14.11) 207(85.89)
Not employed 30(23.62) 97(76.38) 0.023*
Education level
Primary 39(22.94) 131(77.06)
Secondary 25(12.63) 173(87.37) 0.010*
CD4 counts
#200 16 (26.23) 45(73.77)
$201 48(15.64) 259(84.36) 0.049*
Opportunistic
Infection
Yes 19(12.34) 135(87.66) 0.032*
No 45(21.03) 169(78.97)
WHO stage
I 13(14.13) 79 (85.87)
II 26(19.26) 109(80.74) 0.316
III 15(15.79) 80(84.21) 0.751
IV 10(24.39) 31(75.61) 0.153
*denotes p value ,0.05 and statistical significance.
doi:10.1371/journal.pone.0048671.t002
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made using a screening instrument, rather than a diagnostic one.
Our population comprised of medically stable participants who
were generally healthier, and this could explain the lower
prevalence compared to the other Ugandan studies..
AIDS-related stigma, a condition that has been associated with
adverse health outcomes in PLWHA was equally prevalent in the
study population. Our finding about AIDS related stigma is also in
keeping with previous studies that have reported a high burden of
stigma in PLWHA [46–48].
We found an association between major depressive disorder and
AIDS related stigma, meaning that both conditions may be
present in the same HIV-positive individual attending PHC. Our
findings are in keeping with a previous study that documented an
association between depression and stigma in PLWHA [17]. Poor
psychosocial functioning, the presence of opportunistic infections,
poor immune status and the fear of dying from a chronic illness
could explain the existence of either of these conditions, as well as
their association with each other. Previous studies have reported
that stigma among PLWHA is associated with poor psychosocial
functioning [21,49]. It’s possible that people with poor psycho-
logical functioning may develop depression.
Similarly, the presence of opportunistic infections and poor
immune status has been associated with depression in PLWHA
[17,19,45]. It can also be argued that depressed PLWHA who
have opportunistic infections and low CD4+ counts could develop
stigma as a result of their condition. The fear of dying from a
chronic illness may also explain the presence of both conditions.
However, the cross-sectional nature of our study makes it difficult
to establish causality, and the direction of the development of each
condition.
Our findings regarding the association between major depres-
sive disorder and low CD4 counts are in keeping with previous
studies [17,45,50]. These findings could be explained by the fact
that late stage disease (manifested by low CD4 counts) may have
an aetiological role in the development of depression among
PLWHA. The presence of depression in PLWHA could also lead
to a decline in CD4 levels; such an association has been previously
documented [17,50]. It’s also possible that the sicker PLWHA
become, the more likely they are to report symptoms of major
depressive disorder. More work is needed to examine such
hypotheses.
The association between major depressive disorder and younger
age contradicts previous studies where major depressive disorder
was particularly common in older people attending PHC services
[35,36,51]. Perhaps the different contexts in which HIV/AIDS
manifests could explain such differences. Specific neurobiological
factors may play a role in contributing to major depressive
disorder in older subjects; further work is needed to explore this
hypothesis.
A number of limitations in this study deserve emphasis. We
utilised a cross-sectional design, so that causality cannot be fully
addressed. A longitudinal follow-up study could provide better
insight into the precise nature of the relationship between
depression, and the studied factors. That said, PLWHA should
be assessed for both major depressive disorder and AIDS related
stigma since both conditions may present concurrently in the same
individual.
Secondly, the study was conducted in a single PHC site, and
may not be representative of the burden of major depressive
disorder in PLWHA in Uganda.
Thirdly, we didn’t abstract information regarding patients being
on ART, despite the fact that a number of PLWHA at the study
site were accessing ART. This information could have given us
better insight into its relationship with depression and stigma.
Fourth, the instruments we used including the MINI, AIDS
stigma scale, and the PHQ-9 haven’t been validated in Uganda.
This could have led to some inaccuracies in our findings.
However, a number of studies have been conducted in Uganda
using the MINI, and have reported similar prevalence findings to
our study [5,9,52,53]
Despite these limitations, this study reports on the association
between major depression, AIDS stigma and a number of
variables among PLWHA in sub-Saharan Africa. Clinicians
working in HIV settings should regularly assess for both depression
and stigma among clinic attendees, since these conditions may be
present concurrently in PLWHA.
In conclusion, due to the high burden of major depressive
disorder, and its association with AIDS related stigma among
PLWHA, routine screening of PLWHA for both conditions is
recommended. However, further work may be required to
understand the complex relationships between AIDS stigma and
major depressive disorder. Further work to disentangle the
Table 3. Multivariable analysis showing associations between major depression, AIDS related stigma and CD4 counts.
Variable Depressed Unadjusted 95% CI Adjusted 95% CI
(frequency, %) OR OR
Age
18–29 17(26.15)
30–39 27(18.75) 0.65 0.32–1.30
40–49 14(12.96) 0.42* 0.19–0.92 0.95* 0.92–0.98
50+ 6(11.76) 0.37 0.13–1.03
AIDS stigma
Yes 10 (34.48) 1.61* 1.19–2.17 1.65* 1.20–2.26
No 54(15.93)
CD4 counts
#200 16 (26.23)
$201 48(15.64) 0.52* 0.27–0.99 0.43* 0.20–0.91
*denotes p value ,0.05 and statistical significance. Odds ratios adjusted for sex and age.
doi:10.1371/journal.pone.0048671.t003
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relationships between major depressive disorder and low CD4
counts is equally needed.
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